Files and links (2)
Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 20211.66 MB
Published VersionCC BY V4.0, Open Access
Journal article
Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021
International Journal of Environmental Research and Public Health, Vol.19(6), pp.1-14
2022
Appears in Cancer Research Cluster Research Collection
Abstract
Australia and Aotearoa New Zealand have the highest incidence of melanoma and KC in the world. We undertook a cost-of-illness analysis using Markov decision–analytic models separately for melanoma and keratinocyte skin cancer (KC) for each country. Using clinical pathways, the probabilities and unit costs of each health service and medicine for skin cancer management were applied. We estimated mean costs and 95% uncertainty intervals (95% UI) using Monte Carlo simulation. In Australia, the mean first-year costs of melanoma per patient ranged from AU$644 (95%UI: $642, $647) for melanoma in situ to AU$100,725 (95%UI: $84,288, $119,070) for unresectable stage III/IV disease. Australian-wide direct costs to the Government for newly diagnosed patients with melanoma were AU$397.9 m and AU$426.2 m for KCs, a total of AU$824.0 m. The mean costs per patient for melanoma ranged from NZ$1450 (95%UI: $1445, $1456) for melanoma in situ to NZ$77,828 (95%UI $62,525, $94,718) for unresectable stage III/IV disease. The estimated total cost to New Zealand in 2021 for new patients with melanoma was NZ$51.2 m, and for KCs, was NZ$129.4 m, with a total combined cost of NZ$180.5 m. These up-to-date national healthcare costs of melanoma and KC in Australia and New Zealand accentuate the savings potential of successful prevention strategies for skin cancer.
Details
- Title
- Estimated Healthcare Costs of Melanoma and Keratinocyte Skin Cancers in Australia and Aotearoa New Zealand in 2021
- Authors
- Louisa G Gordon (Author) - The University of QueenslandWilliam Leung (Author) - University of OtagoRichard Johns (Author) - Kenmore Clinics (Brisbane, Australia)Bronwen McNoe (Author) - University of OtagoDaniel B Lindsay (Author) - The University of QueenslandKatharina Merollini (Author) - University of the Sunshine Coast, Queensland, School of Health and Behavioural Sciences - LegacyThomas Elliott (Author) - QIMR Berghofer Medical Research InstituteRachel E Neale (Author) - The University of QueenslandCatherine M Olsen (Author) - The University of QueenslandNirmala Pandeya (Author) - The University of QueenslandDavid C Whiteman (Author) - The University of Queensland
- Publication details
- International Journal of Environmental Research and Public Health, Vol.19(6), pp.1-14
- Publisher
- MDPI AG
- Date published
- 2022
- DOI
- 10.3390/ijerph19063178
- ISSN
- 1660-4601; 1661-7827
- Copyright note
- Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/)
- Organisation Unit
- University of the Sunshine Coast, Queensland; Cancer Research Cluster; School of Health and Behavioural Sciences - Legacy; School of Health - Public Health
- Language
- English
- Record Identifier
- 99620507602621
- Output Type
- Journal article
Metrics
3 File views/ downloads
26 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Web Of Science research areas
- Environmental Sciences
- Public, Environmental & Occupational Health
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites